BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 15480328)

  • 1. Adherence logger for a dry powder inhaler: a new device for medical adherence research.
    Bogen D; Apter AJ
    J Allergy Clin Immunol; 2004 Oct; 114(4):863-8. PubMed ID: 15480328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalatory therapy training: a priority challenge for the physician.
    Melani AS
    Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emitted dose estimates from Seretide Diskus and Symbicort Turbuhaler following inhalation by severe asthmatics.
    Tarsin WY; Pearson SB; Assi KH; Chrystyn H
    Int J Pharm; 2006 Jun; 316(1-2):131-7. PubMed ID: 16584855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reliability and patient acceptability of the SmartTrack device: a new electronic monitor and reminder device for metered dose inhalers.
    Foster JM; Smith L; Usherwood T; Sawyer SM; Rand CS; Reddel HK
    J Asthma; 2012 Aug; 49(6):657-62. PubMed ID: 22741746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do healthcare professionals think that dry powder inhalers can be used interchangeably?
    Price D
    Int J Clin Pract Suppl; 2005 Dec; (149):26-9. PubMed ID: 16280000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing the reliability of old and new features of a new electronic monitor for metered dose inhalers.
    Apter AJ; Tor M; Feldman HI
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):421-4. PubMed ID: 11345285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can patients use all dry powder inhalers equally well?
    Gustafsson P; Taylor A; Zanen P; Chrystyn H
    Int J Clin Pract Suppl; 2005 Dec; (149):13-8. PubMed ID: 16279998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a cognitive ergonomics approach to compare usability of a multidose dry powder inhaler and a capsule dry powder inhaler: an open-label, randomized, controlled study.
    Franks M; Briggs P
    Clin Ther; 2004 Nov; 26(11):1791-9. PubMed ID: 15639691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and assessment of co-association in inhalable drug particles using aerosol time-of-flight mass spectrometry.
    New A; Prime D; Zomer S; Elder D; Donovan R; Freney E
    Rapid Commun Mass Spectrom; 2008 Dec; 22(23):3873-82. PubMed ID: 19003851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novolizer: the new technology for the management of asthma therapy.
    Köhler D
    Curr Opin Pulm Med; 2003 Apr; 9 Suppl 1():S11-6. PubMed ID: 12974537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Respimat®, first Soft Mist™ inhaler: new perspectives in the management of COPD].
    Henriet AC; Marchand-Adam S; Mankikian J; Diot P
    Rev Mal Respir; 2010 Dec; 27(10):1141-9. PubMed ID: 21163393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the bronchodilator effect of salbutamol between pressure metered dosed inhaler and dry powder inhaler in patients with stable bronchial asthma].
    Yoshimi Y; Fujimura M; Yasui M; Kasahara K; Nakao S
    Arerugi; 2004 May; 53(5):502-7. PubMed ID: 15247530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of inhaler devices in the management of airway disease.
    Virchow JC; Crompton GK; Dal Negro R; Pedersen S; Magnan A; Seidenberg J; Barnes PJ
    Respir Med; 2008 Jan; 102(1):10-9. PubMed ID: 17923402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, development and performance of a novel multidose dry-powder inhaler.
    Parry-Billings M; Boyes RN; Clisby LM; Braithwaite P; Williams S; Harper AE
    Med Device Technol; 1999 Nov; 10(9):24-8, 30, 32-4. PubMed ID: 10724653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Handling of inhaler devices in actual pulmonary practice: metered-dose inhaler versus dry powder inhalers.
    Khassawneh BY; Al-Ali MK; Alzoubi KH; Batarseh MZ; Al-Safi SA; Sharara AM; Alnasr HM
    Respir Care; 2008 Mar; 53(3):324-8. PubMed ID: 18291048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of an asthma dosing device: the smart-inhaler.
    Burgess SW; Wilson SS; Cooper DM; Sly PD; Devadason SG
    Respir Med; 2006 May; 100(5):841-5. PubMed ID: 16216485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to achieve good compliance and adherence with inhalation therapy.
    Molimard M
    Curr Med Res Opin; 2005; 21 Suppl 4():S33-7. PubMed ID: 16138943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective, randomized cross-over trial to assess the ability of a dry-powder inhaler to reverse the local side effects of pressurized metered-dose inhalers.
    Bhalla RK; Watson G; Taylor W; Jones AS; Roland NJ
    J Asthma; 2008 Nov; 45(9):814-9. PubMed ID: 18972301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is new in asthma: new dry powder inhalers.
    Hannemann LA
    J Pediatr Health Care; 1999; 13(4):159-65. PubMed ID: 10690079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.